The role and therapeutic potential of purinergic signaling pathway in metabolic syndrome-related atherosclerosis
{{output}}
Metabolic syndrome (MetS) is a cluster of interrelated and co-occurring metabolic disorders, including abdominal obesity, hyperglycemia, dyslipidemia, the reduced high-density lipoprotein (HDL) cholesterol, and/or hypertension. Cardiovascular diseases are the ... ...
